In addition, FDI-6, a recent developed small molecule inhibitor of FOXM1 which transcriptionally upregulates CDC25B expression, suppressed CDC25B expression in breast and ovarian cancer cells [207]. This evidence concerns the gene CDC25B and ovarian cancer.